GlassScriptPhysician profile
Brett C Stoll
NPI 1093791071
$9,625.15
in general payments reported to CMS, 2019-2025
42 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,727 · 2020: $770 · 2021: $1,978 · 2022: $2,316 · 2023: $1,825 · 2024: $798 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,833.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,438.51 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $1,122.38 | 2019-2023 | |
| Abbott Laboratories | $1,110.02 | 2019-2025 | Mitraclip, Jot Dx, Cardiomems |
| Astrazeneca Pharmaceuticals LP | $995.97 | 2019-2023 | Farxiga, Andexxa |
| Boston Scientific Corporation | $954.53 | 2019-2024 | Watchman Flx, Wavewriter Alpha Prime 16, Watchman |
| Janssen Pharmaceuticals, INC | $870.17 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $379.01 | 2019-2023 | Lifevest |
| Abiomed | $309.07 | 2019-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $291.89 | 2019-2023 | Camzyos |
| Amgen INC. | $270.23 | 2019-2023 | Repatha |
| Merck Sharp & Dohme LLC | $223.41 | 2021-2023 | Verquvo |
| Pfizer INC. | $206.56 | 2019-2023 | |
| Amarin Pharma, INC. | $178.86 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.84 | 2019-2023 | Jardiance |
| Philips North America LLC | $118.26 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $110.30 | 2023-2025 | Zilver Ptx, Advance |
| Cvrx, INC. | $95.53 | 2024 | Barostim Neo System |
| Stryker Corporation | $73.35 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $69.88 | 2021-2023 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Atricure, INC. | $69.19 | 2024 | |
| Medtronic, INC. | $60.63 | 2021-2022 | |
| Cardinal Health 200 LLC | $53.63 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.97 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $50.53 | 2019 | |
| Esperion Therapeutics, INC. | $41.38 | 2021-2023 | Nexletol |
| Shockwave Medical, INC | $40.53 | 2022 | |
| Cardiva Medical, INC. | $36.23 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $33.57 | 2023 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $25.95 | 2019 | |
| Convatec INC. | $24.73 | 2023 | |
| Baxter Healthcare | $22.06 | 2023 | Hillrom - Eli 380 |
| Biosense Webster, INC. | $19.78 | 2019 | |
| Cardiovascular Systems INC. | $17.75 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $16.92 | 2022 | |
| Biotronik INC. | $16.48 | 2022 | |
| Penumbra, INC. | $16.00 | 2021 | |
| Astellas Pharma US INC | $15.98 | 2019 | |
| Impulse Dynamics (USA) INC. | $14.81 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.54 | 2019 | |
| Medtronic Vascular, INC. | $12.27 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.25 | 2020 | |
| Teleflex LLC | $12.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Stoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.